info icon

This is a non-core endpoint: only basic statistics are computed.

See these related core endpoints for full statistics:

Sequelae of poisoning by drugs, medicaments and biological substances

ST19_SEQUEL_POISO_DRUGS_MEDICAM_BIOLO_SUBST

Endpoint definition

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 T96#
  • Cause of death: ICD-10 T96#

2 out of 7 registries used, show all original rules.

56

4. Check minimum number of events

None

56

5. Include endpoints

None

56

6. Filter based on genotype QC (FinnGen only)

56

Control definitions (FinnGen only)

Control exclude
ST19_SEQUEL_INJURI_POISO_OTHER_CONSE_EXTER_CAUSES

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
T9
Name in latin
Sequelae intoxicationum agentibus psychotropicis, medicamentis et substantiis biologicis

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 56 34 22
Unadjusted period prevalence (%) 0.01 0.01 0.01
Median age at first event (years) 34.48 33.56 35.91

-FinnGen-

Age distribution of first events

010203040500246810121416AgeIndividuals

-FinnGen-

Year distribution of first events

19701975198019851990199520052010201520202023024681012141618YearIndividuals

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
52
Matched controls
519
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
T96
ICD-10 Finland
Sequelae of poisoning by drugs, medicaments and biological substances
+∞
74.4
52
*
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
166.8
38.9
38
8
T36
ICD-10 Finland
Poisoning by systemic antibiotics
101.2
34.9
37
12
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
36.7
17.4
22
10
N05AH04
ATC
quetiapine; oral
14.4
15.8
31
48
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
19.1
14.1
22
19
XF400
NOMESCO Finland
ECG with 12 standard connections
18.1
13.8
22
20
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
93.4
13.3
14
*
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
169.2
13.1
13
*
N05AH03
ATC
olanzapine; systemic
19.4
13.1
20
16
F32.9
ICD-10 Finland
Depressive episode, unspecified
10.5
12.2
27
48
N06AB06
ATC
sertraline; oral
12.3
11.1
21
27
AA1AD
NOMESCO Finland
CT of head and brain
8.8
10.6
26
53
N05AA02
ATC
levomepromazine; systemic
23.3
10.1
14
8
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
11.3
9.8
19
25
N05BA04
ATC
oxazepam; oral
7.2
9.6
28
72
P19
ICPC
Drug abuse
45.4
9.4
11
*
N05AX12
ATC
aripiprazole; systemic
13.9
9.4
16
16
N03AG01
ATC
valproic acid; systemic, rectal
21.1
9.1
13
8
B18.2
ICD-10 Finland
Chronic viral hepatitis C
60.6
9.0
10
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
9.7
9.0
19
29
N06AX11
ATC
mirtazapine; oral
6.3
8.9
32
105
N07BB01
ATC
disulfiram; oral
34.0
8.9
11
*
N06AB04
ATC
citalopram; systemic
6.8
8.8
26
66
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
18.7
8.8
13
9
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
106.7
8.7
9
*
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
+∞
8.6
8
*
N03AE01
ATC
clonazepam; systemic
21.7
8.5
12
7
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
40.3
8.4
10
*
F60.9
ICD-10 Finland
Personality disorder, unspecified
53.3
8.0
9
*
N05AX08
ATC
risperidone; systemic
14.0
7.8
13
12
N05BA01
ATC
diazepam; systemic, rectal
8.8
7.8
17
27
Z72.2
ICD-10 Finland
Drug use
92.8
7.6
8
*
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
92.8
7.6
8
*
P15
ICPC
Chronic alcohol abuse
92.8
7.6
8
*
N05CF01
ATC
zopiclone; oral
5.7
7.6
26
77
F29
ICD-10 Finland
Unspecified nonorganic psychosis
12.9
7.6
13
13
N05AN01
ATC
lithium; oral
35.5
7.4
9
*
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
35.5
7.4
9
*
P01
ICPC
Feeling anxious/nervous/tense
6.7
7.3
20
44
X58
ICD-10 Finland
Exposure to other specified factors
6.9
6.9
18
37
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
21.3
6.5
9
5
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
+∞
6.4
6
*
X78
ICD-10 Finland
Intentional self-harm by sharp object
+∞
6.4
6
*
R40.2
ICD-10 Finland
Coma, unspecified
+∞
6.4
6
*
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
+∞
6.4
6
*
Y19
ICD-10 Finland
Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent
+∞
6.4
6
*
N05CD07
ATC
temazepam; oral
8.7
6.2
13
19
N03AX09
ATC
lamotrigine; oral
11.3
6.1
11
12
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
7.1
6.1
15
28
N05BA12
ATC
alprazolam; oral
8.3
6.0
13
20

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
20
26
11.41
15.50
2.9
2.0
1.26
1.67
mmol/l
0.19
15
20
21
31
10.24
14.73
9.8
1.6
—
—
—
0
0
17
19
12.41
14.56
12.4
2.0
—
—
—
0
0
20
30
9.81
13.78
14.7
2.0
—
—
—
0
0
21
35
9.00
13.24
10.8
1.6
—
—
—
0
0
21
35
9.00
13.24
9.2
1.6
—
—
—
0
0
21
36
8.73
12.89
11.0
1.6
—
—
—
0
0
21
36
8.73
12.89
10.8
1.6
—
—
—
0
0
21
36
8.73
12.89
10.9
1.6
—
—
—
0
0
17
32
7.19
9.36
6.6
24.9
1.06
1.06
mmol/l
0.00
12
24
12
17
8.71
8.35
7.8
31.1
—
—
—
0
0
13
22
7.39
7.77
3.7
12.3
—
—
—
0
0
26
86
4.78
7.58
5.7
4.6
—
—
—
0
0
10
5
23.82
7.43
4.4
3.6
—
—
—
0
0
31
126
4.27
6.74
7.9
10.2
0.98
1.24
inr
—
8
34
11
19
6.96
6.38
3.4
14.6
0.68
0.74
%
0.18
11
19
11
19
6.96
6.38
3.4
14.6
3.47
1.54
%
2.25
11
19
11
21
6.27
5.79
3.4
12.7
1.93
1.10
mmol/l
1.21
11
21
11
23
5.71
5.26
1.8
1.3
—
—
—
0
0
13
33
4.83
5.04
6.5
2.9
229.38
6762.40
u/l
—
5
15
9
10
10.45
4.99
2.8
3.0
1.41
1.72
mmol/l
—
9
10
9
11
9.48
4.76
3.2
2.3
0.60
0.70
%
—
9
11
7
7
11.19
4.13
6.4
10.6
0.49
0.58
mmol/l
—
7
7
36
204
3.14
4.07
8.4
5.0
59.23
56.95
%
0.56
36
198
9
17
6.08
3.68
3.9
16.2
90.80
94.36
%
—
9
17
24
121
2.72
3.19
9.0
4.9
—
—
—
0
0
20
92
2.83
3.15
5.3
3.5
—
—
—
0
0
7
12
6.49
3.12
5.1
2.8
—
—
—
0
0
27
149
2.57
2.95
1.6
1.8
94.37
95.18
pmol/l
0.04
11
82
6
9
7.30
2.94
14.0
10.6
1508.67
1182.11
nmol/l
—
6
9
8
18
5.00
2.92
10.9
42.0
—
—
—
0
0
0
67
0.00
2.62
0.0
1.2
—
—
—
0
0
6
11
5.96
2.61
2.0
2.5
—
—
—
0
0
7
16
4.84
2.56
5.0
5.9
25.14
23.66
mmol/l
—
7
16
21
112
2.40
2.38
3.3
2.7
—
—
—
0
0
18
92
2.41
2.22
3.9
7.7
—
—
—
0
0
27
168
2.17
2.09
4.0
1.9
—
—
—
0
0
9
35
2.87
1.90
6.0
4.7
—
—
—
0
0
6
17
3.82
1.89
1.0
1.2
—
—
—
0
0
40
305
2.09
1.67
8.1
4.2
—
—
—
0
0
16
90
2.09
1.53
1.8
1.6
1.27
1.31
mmol/l
0.10
11
79
5
16
3.32
1.47
1.2
1.1
—
—
—
0
0
20
126
1.91
1.40
7.3
2.9
12.67
39.88
ng/l
0.77
12
73
15
89
1.94
1.23
3.4
1.4
—
—
—
0
0
25
178
1.73
1.15
12.6
7.9
0.00
0.00
e9/l
0.00
18
136
9
45
2.19
1.11
1.4
1.2
—
—
—
0
0
9
47
2.09
1.09
1.6
2.0
420.22
428.05
nmol/l
—
9
41
9
49
1.99
1.05
1.3
1.9
—
—
—
0
0
7
36
2.08
1.01
10.1
25.3
—
1.23
—
0
6
9
51
1.91
1.00
1.4
1.5
—
—
—
0
0
10
55
2.00
0.99
2.3
1.5
—
—
—
0
0
33
262
1.63
0.95
5.6
2.9
—
—
—
0
0
10
61
1.78
0.74
1.1
3.0
—
—
—
0
0
5
27
1.93
0.70
1.2
3.0
—
—
—
0
0
18
132
1.54
0.68
3.8
1.8
—
—
—
0
0
10
65
1.66
0.60
8.0
2.6
563.50
537.70
mosm/kgh2o
—
10
57
17
130
1.44
0.52
8.2
2.6
—
—
—
0
0
22
179
1.38
0.48
5.4
2.8
—
—
—
0
0
6
93
0.60
0.47
2.0
2.9
304.17
8220.19
umol/l
—
6
86
14
105
1.44
0.47
3.1
1.7
—
—
—
0
0
11
79
1.49
0.45
2.8
3.4
1.47
19.48
mg/mmol
—
6
44
0
16
0.00
0.42
0.0
5.1
—
33.19
—
0
16
0
16
0.00
0.42
0.0
1.1
—
1.01
—
0
8
0
17
0.00
0.41
0.0
1.1
—
2.36
—
0
9
9
66
1.43
0.41
1.9
2.3
—
—
—
0
0
47
440
1.42
0.40
23.2
12.6
34.92
41.09
%
1.69
31
360
14
175
0.73
0.38
2.6
2.0
—
—
—
0
0
15
119
1.36
0.37
3.2
4.7
—
—
—
0
0
7
56
1.29
0.31
1.7
2.0
3.00
2.57
g/l
—
7
50
13
154
0.80
0.22
1.5
1.7
—
—
—
0
0
0
10
0.00
0.21
0.0
2.3
—
—
—
0
0
6
48
1.28
0.21
1.2
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
12
105
1.18
0.12
6.0
2.8
—
—
—
0
0
5
43
1.18
0.10
1.4
1.5
—
—
—
0
0
7
83
0.82
0.07
1.3
1.3
—
12.35
—
0
25
14
128
1.13
0.07
2.0
1.4
2.97
2.08
u/ml
—
7
33
11
100
1.12
0.05
2.5
3.0
—
—
—
0
0
14
130
1.10
0.05
3.4
2.1
—
—
—
0
0
11
101
1.11
0.04
6.6
2.8
0.10
0.08
e6/l
0.09
11
76
16
162
0.98
0.00
2.1
1.6
—
—
—
0
0
6
61
0.98
0.00
2.7
3.2
2.41
2.40
mmol/l
—
6
52
5
53
0.94
0.00
1.4
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
44
440
1.00
0.00
4.3
3.5
2.66
2.79
mmol/l
0.40
38
416
0
7
0.00
0.00
0.0
1.0
—
36.03
—
0
7
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
0.87
—
0
5
0
5
0.00
0.00
0.0
3.4
—
1.54
—
0
5
0
6
0.00
0.00
0.0
3.0
—
11.08
—
0
6
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: ST19_SEQUEL_POISO_DRUGS_MEDICAM_BIOLO_SUBST – Sequelae of poisoning by drugs, medicaments and biological substances

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).